Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide dosing follows a structured titration schedule designed to minimize side effects while building tolerance to the medication. Most people begin with 0.25 mg weekly and increase incrementally every four weeks, but individual response varies widely based on genetics, metabolism, and overall health. Understanding whether a dose increase is right for you requires tracking both weight loss progress and how your body tolerates the medication.

How Semaglutide Dosing Typically Works

Semaglutide follows a standard titration protocol that starts low and increases gradually over 16 weeks. The typical sequence begins at 0.25 mg once weekly for four weeks, then moves to 0.5 mg weekly for the next month, followed by 0.75 mg, and finally 1.0 mg as the maintenance dose. This stepped approach allows your digestive system and appetite-regulating hormones to adapt, reducing nausea and other adjustment symptoms. Some patients remain effective at lower doses, while others benefit from continuing to 1.7 mg or 2.0 mg for enhanced results.

Your dose may need adjustments based on your individual response, not your body weight or how much weight you've lost. Many people reach their target weight loss at doses lower than the maximum available strength, making further increases unnecessary. PlexusDx compounded semaglutide injections maintain flat monthly pricing across all dose levels—your dose may increase, but your cost stays the same at $149 per month or higher commitment tiers.

Signs You May Benefit From a Dose Increase

If you've been on your current semaglutide dose for six to eight weeks and notice your appetite has returned, weight loss has plateaued, or cravings are becoming difficult to manage, these are signals your body may be ready for the next dose level. Some patients experience what's called tachyphylaxis—a gradual reduction in the medication's effect over time—which can make a dose increase necessary to maintain results. However, a plateau after two to three months of excellent weight loss may simply reflect your body reaching a natural equilibrium and does not automatically require dosing up.

Your healthcare provider should assess whether increased appetite genuinely reflects reduced medication effectiveness or whether other factors like stress, sleep changes, or hormonal shifts are at play. A modest weight loss slowdown after rapid initial losses is metabolically normal and may not warrant adjustment. PlexusDx providers consider your complete clinical picture, including genetic predispositions identified through the Precision Peptide Genetic Test, to personalize dose timing.

When to Stay at Your Current Semaglutide Dose

Many people achieve their weight loss goals without ever reaching the maximum recommended dose, and remaining at a lower, well-tolerated dose is medically sound if results are steady and side effects are minimal. If you're losing one to two pounds weekly, managing your eating habits without constant struggle, and feel energized, there's no clinical reason to increase your dose. Some patients experience significant appetite suppression and satiety improvements at 0.5 mg or 0.75 mg and maintain that benefit for months without needing more.

Dose stability also matters for long-term treatment adherence and quality of life. Staying at a dose that delivers results without triggering severe nausea, constipation, or fatigue may improve your likelihood of continuing treatment successfully. Your healthcare provider can help you set realistic, sustainable weight loss targets so you know when your current dose is genuinely sufficient versus when an increase would provide added benefit.

The Role of Genetic Testing in Personalizing Your Semaglutide Dose

PlexusDx offers the Precision Peptide Genetic Test, a $99 add-on after your first month of treatment, which identifies how your genes influence GLP-1 receptor sensitivity, appetite regulation, and weight metabolism. Key genetic markers like GLP1R rs6923761 and FTO rs9939609 help predict whether your body will respond optimally to standard doses or whether a more personalized approach may accelerate results. This test maps 14 biological pathways across 49 peptides, revealing up to 150+ genetic insights specific to your weight loss physiology.

Understanding your genetic peptide profile empowers more targeted dosing decisions rather than following a one-size-fits-all schedule. If testing reveals you have genetic variants associated with strong GLP-1 receptor response, for example, you may achieve excellent results at lower doses and lower costs. Conversely, if your genetics suggest reduced GLP-1 sensitivity, your provider can proactively plan for dose increases earlier in your treatment timeline, optimizing your weight loss trajectory from the start.

Comparing Semaglutide Dose Increases to Other GLP-1 Options

Semaglutide is one of several GLP-1 medications available through PlexusDx, and dose-increase needs can vary depending on which compound you choose. Tirzepatide, a dual GIP/GLP-1 receptor agonist, often produces weight loss results at lower doses compared to semaglutide alone, potentially reducing your need for frequent dose adjustments. PlexusDx also offers GLP-Squared, a compounded dual-agent injection combining semaglutide and tirzepatide, which some patients find maximizes results at moderate dose levels without escalating either compound alone.

Oral semaglutide carries similar dosing principles to injections but may require higher doses (up to 14 mg daily) because of lower bioavailability compared to weekly injections. PlexusDx oral semaglutide starts at $249 per month with flat pricing across all oral dose strengths. Discussing which medication and delivery form aligns with your genetics, lifestyle, and goals helps your provider recommend a starting dose and adjustment strategy tailored specifically to you.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How often should I increase my semaglutide dose?

Most people increase every four to eight weeks based on tolerance and appetite response, following a structured titration plan. Your PlexusDx provider adjusts timing based on your individual tolerance, genetic predispositions from the Precision Peptide test, and weight loss progress—not a fixed calendar schedule.

Will I definitely need to reach the maximum semaglutide dose?

No. Many patients achieve excellent, sustainable weight loss at 0.75 mg or 1.0 mg and never need higher doses. Your healthcare provider assesses whether your current dose is delivering results and managing side effects well before recommending an increase.

Does PlexusDx charge more for higher semaglutide doses?

No. PlexusDx compounded semaglutide injections cost $149 per month flat—your price stays the same whether you're at 0.25 mg or 2.0 mg. This pricing model removes financial barriers to finding your optimal dose.

What side effects suggest I should skip a dose increase?

Persistent nausea, severe constipation, vomiting, or abdominal pain may signal your current dose is already maximal for your tolerance. Increasing further could worsen side effects without improving results. Talk to your provider about staying stable or adjusting other medications to manage symptoms.

How does the Precision Peptide Genetic Test predict whether I'll need dose increases?

The test identifies genetic variants in GLP1R, GIPR, FTO, and MC4R that influence appetite hormone sensitivity and weight metabolism. These insights help your PlexusDx provider anticipate whether you'll likely respond well at lower doses or benefit from earlier, planned increases for faster, more predictable weight loss.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves